• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的免疫发病机制。

The immune pathogenesis of multiple sclerosis.

机构信息

Department of Neurology, University of Regensburg, Universitaetsstrasse 84, 93053 Regensburg, Germany.

出版信息

J Neuroimmune Pharmacol. 2013 Sep;8(4):857-66. doi: 10.1007/s11481-013-9467-3. Epub 2013 May 10.

DOI:10.1007/s11481-013-9467-3
PMID:23660832
Abstract

Multiple sclerosis is an autoimmune disease of the central nervous system (CNS) that leads to changes of nerve conduction due to damage of CNS- resident cells, primarily oligodendrocytes and neurons. CD4+ T cells are of primary importance in the immune cascades leading to tissue damage, but also CD8+ T cells, NK cells and B cells and antibodies contribute to tissue damage. In addition, the innate immune response and mainly microglial cells participate in the events leading to lesions. There are different types of MS and possibly this is due to different underlying immune mechanisms. The current treatment options mainly affect the immune response but have not much influence on secondary signaling changes in astrocytes and neurons which contribute to constant disease progression. The immune response in MS must be seen in the systemic context and there are strong indications that the gut and lung immunity affect MS disease precipitation. The strongest genetic influence in MS is mediated by the HLA class II genes and in Western Europeans and North Americans the disease is associated with HLA-DR2b. Possibly this is due to presentation of a set of specific antigens in context of this HLA allele. Novel data indicates that the immune response in MS is not only focused on certain myelin proteins like myelin basic protein (MBP) but to additional astrocytic and neuronal proteins, which is also mirrored in the pathology. While in the past the disease has been considered as mainly a white matter disease, nowadays it is clear that also grey matter is affected by the aberrant immune response. Still much needs to be learned regarding the underlying events in MS. This expanded knowledge is important to finally discover curative therapies.

摘要

多发性硬化症是一种中枢神经系统(CNS)的自身免疫性疾病,由于中枢神经系统固有细胞(主要是少突胶质细胞和神经元)的损伤,导致神经传导发生变化。CD4+T 细胞在导致组织损伤的免疫级联反应中起着主要作用,但 CD8+T 细胞、NK 细胞和 B 细胞以及抗体也有助于组织损伤。此外,先天免疫反应和主要的小胶质细胞参与导致病变的事件。多发性硬化症有不同的类型,这可能是由于不同的潜在免疫机制。目前的治疗选择主要影响免疫反应,但对星形胶质细胞和神经元的二次信号变化影响不大,这些变化有助于持续的疾病进展。多发性硬化症中的免疫反应必须从全身角度来看待,并且有强烈的迹象表明肠道和肺部免疫会影响多发性硬化症的发病。多发性硬化症最强的遗传影响是由 HLA Ⅱ类基因介导的,在西欧人和北美人群中,该疾病与 HLA-DR2b 相关。可能这是由于在这个 HLA 等位基因的背景下,呈现出一组特定的抗原。新的数据表明,多发性硬化症中的免疫反应不仅集中在某些髓鞘蛋白(如髓鞘碱性蛋白,MBP)上,还针对额外的星形胶质细胞和神经元蛋白,这在病理学上也有反映。虽然过去该疾病被认为主要是一种白质疾病,但现在很清楚,异常的免疫反应也会影响灰质。关于多发性硬化症的潜在事件,还有很多需要了解。这些扩展的知识对于最终发现治疗方法非常重要。

相似文献

1
The immune pathogenesis of multiple sclerosis.多发性硬化症的免疫发病机制。
J Neuroimmune Pharmacol. 2013 Sep;8(4):857-66. doi: 10.1007/s11481-013-9467-3. Epub 2013 May 10.
2
Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.多发性硬化症的自身免疫发病机制:自身反应性T淋巴细胞的作用及新的免疫治疗策略。
Crit Rev Immunol. 1997;17(1):33-75. doi: 10.1615/critrevimmunol.v17.i1.20.
3
Multiple sclerosis: immune mechanism and update on current therapies.多发性硬化症:免疫机制及当前治疗进展
Ann Neurol. 1995 May;37 Suppl 1:S87-101. doi: 10.1002/ana.410370710.
4
Multiple sclerosis pathogenesis: missing pieces of an old puzzle.多发性硬化症发病机制:旧谜题中的缺失部分。
Rev Neurosci. 2018 Dec 19;30(1):67-83. doi: 10.1515/revneuro-2018-0002.
5
HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis.人类内源性逆转录病毒包膜、Epstein-Barr 病毒和脑蛋白中的 HLA DR2b 结合肽在多发性硬化症中的分子模拟。
Immunol Lett. 2020 Jan;217:15-24. doi: 10.1016/j.imlet.2019.10.017. Epub 2019 Nov 3.
6
Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.EBV 特异性 CD8 T 细胞在多发性硬化症中选择性浸润大脑并与病毒感染细胞局部相互作用:病毒驱动免疫病理机制的线索。
J Virol. 2019 Nov 26;93(24). doi: 10.1128/JVI.00980-19. Print 2019 Dec 15.
7
Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factors.多发性硬化症病变发展的机制:调和自身免疫和神经退行性因素。
CNS Neurol Disord Drug Targets. 2012 Aug;11(5):556-69. doi: 10.2174/187152712801661293.
8
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.先天、先天样和适应性淋巴细胞在 MS 和 EAE 发病机制中的作用。
Cell Mol Immunol. 2019 Jun;16(6):531-539. doi: 10.1038/s41423-019-0221-5. Epub 2019 Mar 15.
9
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.一种利用HLA - DR2和人类T细胞受体的多发性硬化症人源化模型。
Nat Genet. 1999 Nov;23(3):343-7. doi: 10.1038/15525.
10
Neuronal injury in chronic CNS inflammation.慢性中枢神经系统炎症中的神经元损伤。
Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29.

引用本文的文献

1
Current and Emerging Assays for Measuring Human T-Cell Responses Against Beta-Cell Antigens in Type 1 Diabetes.用于测量1型糖尿病患者针对β细胞抗原的人T细胞反应的现有及新兴检测方法
Biomolecules. 2025 Mar 6;15(3):384. doi: 10.3390/biom15030384.
2
Understanding immune microenvironment alterations in the brain to improve the diagnosis and treatment of diverse brain diseases.了解大脑中免疫微环境的改变,以改善多种脑部疾病的诊断和治疗。
Cell Commun Signal. 2024 Feb 17;22(1):132. doi: 10.1186/s12964-024-01509-w.
3
Multiple sclerosis and mental health related quality of life: The role of defense mechanisms, defense styles and family environment.

本文引用的文献

1
2-photon imaging of phagocyte-mediated T cell activation in the CNS.双光子成像技术在中枢神经系统中观察吞噬细胞介导的 T 细胞活化
J Clin Invest. 2013 Mar;123(3):1192-201. doi: 10.1172/JCI67233. Epub 2013 Feb 1.
2
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.靶向原发性进行性多发性硬化症中的 ASIC1:阿米洛利具有神经保护作用的证据。
Brain. 2013 Jan;136(Pt 1):106-15. doi: 10.1093/brain/aws325.
3
Human hemato-lymphoid system mice: current use and future potential for medicine.人血液-淋巴系统小鼠:在医学中的当前应用和未来潜力
多发性硬化症与心理健康相关生活质量:防御机制、防御方式及家庭环境的作用
AIMS Neurosci. 2023 Nov 27;10(4):354-375. doi: 10.3934/Neuroscience.2023027. eCollection 2023.
4
Dissecting regulatory T cell expansion using polymer microparticles presenting defined ratios of self-antigen and regulatory cues.利用呈现特定比例自身抗原和调节信号的聚合物微粒剖析调节性T细胞的扩增。
Front Bioeng Biotechnol. 2023 Jun 27;11:1184938. doi: 10.3389/fbioe.2023.1184938. eCollection 2023.
5
Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment.组蛋白修饰剂诱导的针对自身免疫性脑脊髓炎的保护作用对多发性硬化症治疗的影响。
Front Neurol. 2022 Oct 14;13:980758. doi: 10.3389/fneur.2022.980758. eCollection 2022.
6
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.肠道微生物组在人类神经疾病中的作用的综合综述。
Clin Microbiol Rev. 2022 Jan 19;35(1):e0033820. doi: 10.1128/CMR.00338-20. Epub 2022 Jan 5.
7
GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35.GANAB作为多发性硬化症的一种新型生物标志物:与神经炎症和IFI35的相关性
Pharmaceuticals (Basel). 2021 Nov 21;14(11):1195. doi: 10.3390/ph14111195.
8
Association of HLA-DR2-Related Haplotype (HLA-DRB5*01-DRB1*1501-DQB1*0602) in Patients with Multiple Sclerosis in Khuzestan Province.胡齐斯坦省多发性硬化症患者中HLA - DR2相关单倍型(HLA - DRB5*01 - DRB1*1501 - DQB1*0602)的关联
Iran J Child Neurol. 2021 Summer;15(3):35-46. doi: 10.22037/ijcn.v14i4.18795.
9
The Effect of Coffee and Caffeine Consumption on Patients with Multiple Sclerosis-Related Fatigue.咖啡和咖啡因摄入对多发性硬化相关性疲劳患者的影响。
Nutrients. 2020 Jul 28;12(8):2262. doi: 10.3390/nu12082262.
10
Aging, Cellular Senescence, and Progressive Multiple Sclerosis.衰老、细胞衰老与进展性多发性硬化症
Front Cell Neurosci. 2020 Jun 30;14:178. doi: 10.3389/fncel.2020.00178. eCollection 2020.
Annu Rev Immunol. 2013;31:635-674. doi: 10.1146/annurev-immunol-032712-095921. Epub 2013 Jan 16.
4
Clinically feasible MTR is sensitive to cortical demyelination in MS.临床可行的 MTR 对 MS 的皮质脱髓鞘敏感。
Neurology. 2013 Jan 15;80(3):246-52. doi: 10.1212/WNL.0b013e31827deb99. Epub 2012 Dec 26.
5
Vitamin D as a protective factor in multiple sclerosis.维生素 D 作为多发性硬化症的保护因素。
Neurology. 2012 Nov 20;79(21):2140-5. doi: 10.1212/WNL.0b013e3182752ea8.
6
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.口服 BG-12 治疗复发型多发性硬化症的安慰剂对照 3 期研究。
N Engl J Med. 2012 Sep 20;367(12):1098-107. doi: 10.1056/NEJMoa1114287.
7
T cells become licensed in the lung to enter the central nervous system.T 细胞在肺部获得进入中枢神经系统的许可。
Nature. 2012 Aug 30;488(7413):675-9. doi: 10.1038/nature11337.
8
T-cell trafficking in the central nervous system.T 细胞在中枢神经系统中的迁移。
Immunol Rev. 2012 Jul;248(1):216-27. doi: 10.1111/j.1600-065X.2012.01140.x.
9
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.纳武利尤单抗相关进行性多灶性白质脑病的风险。
N Engl J Med. 2012 May 17;366(20):1870-80. doi: 10.1056/NEJMoa1107829.
10
Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity.自身抗原构象影响 B 细胞和 T 细胞反应及致脑炎活性。
J Biol Chem. 2012 May 18;287(21):17206-17213. doi: 10.1074/jbc.M111.304246. Epub 2012 Apr 5.